Milae Bioresources Co., Ltd. (KOSDAQ:218150)

Milae Bioresources Income Statement

Financials in millions KRW. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jun 30, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Other Revenue	-	-	-	-	-	0
Revenue	63,888	62,453	60,016	75,635	66,668	47,497
Revenue Growth (YoY)	4.45%	4.06%	-20.65%	13.45%	40.36%	-5.16%
Cost of Revenue	55,323	54,554	51,911	66,210	58,308	40,821
Gross Profit	8,565	7,900	8,105	9,425	8,361	6,676
Selling, General & Admin	6,312	6,574	6,943	6,757	5,530	4,275
Research & Development	528.43	545.24	534.89	521.61	461.83	504.36
Amortization of Goodwill & Intangibles	270.88	114.02	153.7	183.97	170.86	43.22
Other Operating Expenses	45.11	43.34	40.55	56.06	14.76	15.67
Operating Expenses	7,609	7,716	8,084	7,842	6,506	5,517
Operating Income	956.38	183.74	20.19	1,583	1,855	1,159
Interest Expense	-536.68	-439.5	-399.63	-685.42	-778.2	-235.43
Interest & Investment Income	478.42	731.35	1,008	366.78	116.75	135.58
Currency Exchange Gain (Loss)	-19.82	-9.52	-13.87	-4.61	2.25	-14.55
Other Non Operating Income (Expenses)	-48.38	-114.25	-12.44	-63.6	-16.15	41.12
EBT Excluding Unusual Items	1,286	351.81	601.8	1,196	1,180	1,086
Gain (Loss) on Sale of Investments	-	-	1.6	-303.33	-41.2	-54.97
Gain (Loss) on Sale of Assets	30.19	5.88	6.94	12.8	5.73	3.21
Asset Writedown	-875.01	-875.01	-356.45	-	-	-
Other Unusual Items	-	-	139.06	-	-	-
Pretax Income	441.37	-517.31	392.95	905.4	1,144	1,034
Income Tax Expense	56.02	-97.58	33.74	27.25	65.28	81.11
Earnings From Continuing Operations	385.35	-419.73	359.21	878.15	1,079	953.2
Minority Interest in Earnings	-178.46	-13.77	82.14	84.62	63.79	-1.37
Net Income	206.89	-433.5	441.35	962.77	1,143	951.83
Net Income to Common	206.89	-433.5	441.35	962.77	1,143	951.83
Net Income Growth	-	-	-54.16%	-15.75%	20.05%	-7.57%
Shares Outstanding (Basic)	19	19	19	19	18	18
Shares Outstanding (Diluted)	19	19	19	19	18	18
Shares Change (YoY)	-0.91%	1.34%	2.90%	5.51%	-0.06%	-0.13%
EPS (Basic)	10.61	-22.24	22.94	51.50	64.49	53.68
EPS (Diluted)	10.61	-22.24	22.94	51.00	64.00	53.68
EPS Growth	-	-	-55.02%	-20.31%	19.22%	-7.45%
Free Cash Flow	2,052	-1,069	2,603	706.43	2,452	632.76
Free Cash Flow Per Share	105.25	-54.83	135.29	37.78	138.38	35.69
Gross Margin	13.41%	12.65%	13.50%	12.46%	12.54%	14.06%
Operating Margin	1.50%	0.29%	0.03%	2.09%	2.78%	2.44%
Profit Margin	0.32%	-0.69%	0.73%	1.27%	1.71%	2.00%
Free Cash Flow Margin	3.21%	-1.71%	4.34%	0.93%	3.68%	1.33%
EBITDA	2,722	1,357	1,076	2,612	2,776	1,880
EBITDA Margin	4.26%	2.17%	1.79%	3.45%	4.16%	3.96%
D&A For EBITDA	1,765	1,173	1,056	1,029	920.77	720.23
EBIT	956.38	183.74	20.19	1,583	1,855	1,159
EBIT Margin	1.50%	0.29%	0.03%	2.09%	2.78%	2.44%
Effective Tax Rate	12.69%	-	8.59%	3.01%	5.71%	7.84%
Advertising Expenses	-	331.9	515.17	418.44	106.4	8.68

Updated Jun 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.